These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 20306237)
1. Single-batch production of recombinant human polyclonal antibodies. Nielsen LS; Baer A; Müller C; Gregersen K; Mønster NT; Rasmussen SK; Weilguny D; Tolstrup AB Mol Biotechnol; 2010 Jul; 45(3):257-66. PubMed ID: 20306237 [TBL] [Abstract][Full Text] [Related]
2. CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Kim JY; Kim YG; Lee GM Appl Microbiol Biotechnol; 2012 Feb; 93(3):917-30. PubMed ID: 22159888 [TBL] [Abstract][Full Text] [Related]
3. Production of target-specific recombinant human polyclonal antibodies in mammalian cells. Wiberg FC; Rasmussen SK; Frandsen TP; Rasmussen LK; Tengbjerg K; Coljee VW; Sharon J; Yang CY; Bregenholt S; Nielsen LS; Haurum JS; Tolstrup AB Biotechnol Bioeng; 2006 Jun; 94(2):396-405. PubMed ID: 16596663 [TBL] [Abstract][Full Text] [Related]
5. Productivity and quality of recombinant proteins produced by stable CHO cell clones can be predicted by transient expression in HEK cells. Diepenbruck C; Klinger M; Urbig T; Baeuerle P; Neef R Mol Biotechnol; 2013 Jun; 54(2):497-503. PubMed ID: 22915356 [TBL] [Abstract][Full Text] [Related]
6. Benchmarking of commercially available CHO cell culture media for antibody production. Reinhart D; Damjanovic L; Kaisermayer C; Kunert R Appl Microbiol Biotechnol; 2015 Jun; 99(11):4645-57. PubMed ID: 25846330 [TBL] [Abstract][Full Text] [Related]
7. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality. Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762 [TBL] [Abstract][Full Text] [Related]
8. Intracellular response to process optimization and impact on productivity and product aggregates for a high-titer CHO cell process. Handlogten MW; Lee-O'Brien A; Roy G; Levitskaya SV; Venkat R; Singh S; Ahuja S Biotechnol Bioeng; 2018 Jan; 115(1):126-138. PubMed ID: 28941283 [TBL] [Abstract][Full Text] [Related]
9. Rapid establishment of CHO cell lines producing the anti-hepatocyte growth factor antibody SFN68. Song SW; Lee SJ; Kim CY; Han B; Oh JW J Microbiol Biotechnol; 2013 Aug; 23(8):1176-84. PubMed ID: 23727793 [TBL] [Abstract][Full Text] [Related]
11. A strategy for clone selection under different production conditions. Legmann R; Benoit B; Fedechko RW; Deppeler CL; Srinivasan S; Robins RH; McCormick EL; Ferrick DA; Rodgers ST; Russo AP Biotechnol Prog; 2011; 27(3):757-65. PubMed ID: 21448991 [TBL] [Abstract][Full Text] [Related]
12. Increased recombinant protein production owing to expanded opportunities for vector integration in high chromosome number Chinese hamster ovary cells. Yamano N; Takahashi M; Ali Haghparast SM; Onitsuka M; Kumamoto T; Frank J; Omasa T J Biosci Bioeng; 2016 Aug; 122(2):226-31. PubMed ID: 26850366 [TBL] [Abstract][Full Text] [Related]
13. Dynamic model for CHO cell engineering. Nolan RP; Lee K J Biotechnol; 2012 Mar; 158(1-2):24-33. PubMed ID: 22285956 [TBL] [Abstract][Full Text] [Related]
15. Enhancing effect of low culture temperature on specific antibody productivity of recombinant Chinese hamster ovary cells: clonal variation. Yoon SK; Hwang SO; Lee GM Biotechnol Prog; 2004; 20(6):1683-8. PubMed ID: 15575699 [TBL] [Abstract][Full Text] [Related]
16. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures. Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088 [TBL] [Abstract][Full Text] [Related]
17. Determination of Chinese hamster ovary cell line stability and recombinant antibody expression during long-term culture. Bailey LA; Hatton D; Field R; Dickson AJ Biotechnol Bioeng; 2012 Aug; 109(8):2093-103. PubMed ID: 22896849 [TBL] [Abstract][Full Text] [Related]
18. Reducing recombinant protein expression during CHO pool selection enhances frequency of high-producing cells. Poulain A; Mullick A; Massie B; Durocher Y J Biotechnol; 2019 Apr; 296():32-41. PubMed ID: 30885656 [TBL] [Abstract][Full Text] [Related]
19. High-level expression of full-length antibodies using trans-complementing expression vectors. Bianchi AA; McGrew JT Biotechnol Bioeng; 2003 Nov; 84(4):439-44. PubMed ID: 14574701 [TBL] [Abstract][Full Text] [Related]
20. Advancement in recombinant protein production using a marine oxygen carrier to enhance oxygen transfer in a CHO-S cell line. Le Pape F; Bossard M; Dutheil D; Rousselot M; Polard V; Férec C; Leize E; Delépine P; Zal F Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):186-95. PubMed ID: 25961365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]